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Abstract
Acquired immune deficiency syndrome (AIDS) is a
worldwide public health problem and an incurable
disease. The roles of Traditional Chinese Medicine
(TCM) on AIDS had been recognized and accepted
by more and more people. Being a relatively long
period, to initiate combination antiretroviral thera-
py (cART) for the asymptomatic human immunode-
ficiency virus (HIV) infection patient is not consen-
sus. According to TCM theory, not only the imbal-
ance of Yin and Yang but also the disharmony of
internal body function and external natural envi-
ronment had occurred in the body of the patient,
the imbalance and the disharmony should be ad-
justed by the means of the treatment based on
the patters identified among the symptoms in
terms of TCM. We aimed to analyze the feature of
patients with asymptomatic infection, and com-
pare the advantages and disadvantages of the us-
age of cART for asymptomatic infection, explored
the possible mechanism underlying TCM treat-
ment of the asymptomatic infection, by reviewing
the TCM treatment progress on asymptomatic HIV
infection.
© 2015 JTCM. All rights reserved.
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INTRODUCTION
Acquired immune deficiency syndrome (AIDS) is a
quite complex disease caused by the human immuno-
deficiency virus (HIV) infection.1 The immune system
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would be destroyed gradually once HIV invades hu-
man body and leaves the body vulnerable to opportu-
nistic infections and life-threatening cancers. Being an
emerging infectious disease, the prospect of an effective
HIV vaccine to contain the pandemic remains uncer-
tain,2 and there was no recognized cure for the condi-
tions except for a few cured cases reported.3,4
Since 1996, the combination antiretroviral therapy
(cART) was introduced for the to treat the patients
with advanced AIDS, it has reduced HIV-related the
morbidity and mortality drastically.5 But the effect of
cART on patients with asymptomatic infection is still
uncertain.
In this article, we will analysis the feature of patients
with asymptomatic infection, compare the advantages
and defects of the usage of cART for asymptomatic in-
fection, explore the possible mechanism behind the
treatment of asymptomatic infection with Traditional
Chinese Medicine (TCM) by reviewing the TCM treat-
ment progress on asymptomatic HIV infection.
FEATURE OF ASYMPTOMATIC HIV
INFECTION
The progresses of AIDS can be divided into such three
stages: acute HIV infection stage, asymptomatic HIV
infection stage, and AIDS stage.6
Generally, following the stage of acute infection, regard-
less of detectable or undetectable symptoms, patients
enter a stage of asymptomatic infection which always
is regarded as a relatively longest period, people who
are infected with HIV may have no symptoms (i.e.
AIDS defined symptoms or diseases) for almost 6-8
years or longer, but only for a week or month in
acute HIV infection stage, and less than 2-3 years in
early symptomatic HIV infection and advanced
AIDS stage. So the asymptomatic HIV infection
stage is regarded as the longest period among those
three stages.
In asymptomatic stage, the progress of the disease is
still going on, some dangers and risks are existing (the
immune system would be weakened gradually, HIV
can be transmitted from HIV+ patient to the others,
some HIV-related or no-HIV-related symptoms and
signs are still common). Those symptoms or signs
might negatively affect quality of life, adherence, viro-
logical response and survival,7 and should be treated
immediately. Furthermore, the patient often suffers the
stigma and discrimination from social and family, and
the the quality of life is much lower than the normal
one.
Therefore, it is necessity to offer treatments or inter-
ventions for those patients with asymptomatic HIV
infection, and to prolong the asymptomatic HIV in-
fection stage through various methods is also impor-
tant.
ADVANTAGES AND
DISADVANTAGES OF cART FORTHE
TREATMENT OFTHE
ASYMPTOMATIC INFECTION
The cART is a effective therapy in the advanced AIDS
stage, but the HIV cannot be eliminated from patient's
body, so they must take lifelong medication.
However, there is still no consensus on the right timing
for administering cART in individuals infected with
HIV,8 especially no consensus on that any HIV+ per-
sons in asymptomatic HIV-infection with CD4+T cell
counts above 350 cells/μL should initiate cART (i.e.
early therapy);9 e.g. the 2013 World Health Organiza-
tion (WHO) treatment guidelines strongly recom-
mend cART should be initiated for all patients with
CD4+Tcell counts 500 cells/μL or less;10 cART always
is recommend in any HIV-positive person with a cur-
rent CD4+T cell counts below 350 cells/ml and consid-
ered below 500 CD4 + Tcells/μL in the guidelines of
European AIDS Clinical Society (EACS)11 and UK;12
and the United states recommended that cART be ad-
ministered for any HIV-positive persons no matter
what their CD4 T cell counts were.13
It is noteworthy that the benefits and risks of the early
therapy are still under discussion. Some researches dem-
onstrated the benefits from early treatment recently,14
for example, the early therapy can reduce rates of sexu-
al transmission of HIV-1 and clinical events,15 improve
the survival rate of patients living with HIV,16 delay the
progression of asymptomatic HIV infection to AIDS,17
decrease the risk of opportunity infections and
non-AIDS defined incidents18 (prominently included
hepatic, cardiovascular, and pulmonary diseases, as well
as non-AIDS malignancies), and enhance the recon-
struction of impaired immune function.19 As some re-
searchers have worried, there may be some risks and
dangers for early therapy, such as increasing the adverse
effects of cART, reducing the patient treatment compli-
ance, enhancing the drug resistance, and reducing the
opportunity of using cART.20
Briefly, the timing of initiating cART is not absolutely
consensus, the benefits and shortcomings from early
therapy should be confirmed through more researches,
for we have to find a best joint-point between individu-
al benefits (reduced risk of mortality, progression to
AIDS or death, and diagnosis of an AIDS defining ill-
ness) and population benefits (prevention of HIV-1 in-





TCM has a long history of thousands years. Its thera-
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peutic philosophy and treatment methods are different
from the convenient medicine.21
TCM has a theory system rooting in clinical applica-
tion. Its practitioners do believe that the diseases are
understandable, preventable and curable. The thought
of "preventive treatment theory" has existed for thou-
sands years, which emphasizes the importance of dis-
ease prevention and early-stage treatment and stands
for the characteristic and essence of the TCM. In order
to hold back or delay the progression after HIV infec-
tion, they often suggest their patients pay more atten-
tions to recuperating, and regulating emotion, diet sec-
tion, moderate exercise and initiate the early therapy,
when they treat their patients.
TCM plays an important role in primary care in Chi-
na. It often is used for infection disease treating, and
some infection diseases had been successfully cured
and controlled such as severe acute respiratory syn-
dromes,22 influenza A virus subtype H1N1,23 epidemic
encephalitis B,24 and hepatitis,25 etc.
According to TCM theory, AIDS is an infectious dis-
ease because of the invasion of the pathogen. Although
the asymptomatic HIV infection stage is quite long,
and the progress of the disease is still going on rather
than no progress. In asymptomatic HIV infection
stage, not only the imbalance of Yin and Yang but also
the disharmony of internal body function and external
natural environment had occurred in the body of the
patient for TCM believes that the human body is an or-
ganic whole which is made of "Yin and Yang" or "Qi
and Xue", and the imbalance and/or disharmony
should be adjusted to avoid further damages. In other
words, if we give positive intervention to eliminate the
discomfort of patient with asymptomatic stage, the dis-
ease progression would be prolonged and other dangers
would be decreased, especially when the effect of early
therapy is not confirmed. So the asymptomatic HIV in-




In the last 30 years, the progress on TCM treatment of
AIDS has been made promoted by the State Adminis-
tration of Traditional Chinese Medicine of China. A pi-
lot program was conducted to treat AIDS by combin-
ing TCM with anti-retroviral therapy funded by Na-
tional Science Foundation, National 973 Program, and
National 863 Project etc.
As we had known, TCM practitioners had demonstrat-
ed the clinical effects of TCM on AIDS stage, such as
reducing plasma HIV viral loads,27 increasing CD4+T
cell counts,28 promoting immunity reconstitution,29
ameliorating symptoms and signs,30 improving the
health related quality of life,31 and counteracting
against the effects of anti-retroviral drugs,32 etc.
By contrast, the far fewer studies or observations of
TCM had been carried out for patient with asymptom-
atic HIV infection than to AIDS patient. But research-
er had initiated to believe that TCM can be used to
treat patient with asymptomatic HIV infection,33 some
studies had demonstrated that TCM can be used to
treat patients with asymptomatic HIV infection,34,35
and the progression of asymptomatic HIV infection
can be delayed significantly by TCM intervention.36,37
Briefly, the importance of the treatment effects of pa-
tients with asymptomatic HIV infection with TCM
has been recognized and accepted by some of patients
and TCM practitioners in China, and the further re-
search had been carried out to confirm those effects of
the treatment of asymptomatic HIV infection with





AIDS caused by HIV infection. If the infection is not
detected and treated, the immune system gradually
weakens and AIDS develops. As a matter of course,
CD4+T cell counts and HIV loads had been recom-
mended as evaluation and monitoring approach for
cART,38 and has been used globally.
By contrast, efficacy assessment of TCM may be quite
different to that of WM. For TCM rely on a holistic
approach, conventional efficacy assessment measures
may not be adequate. Thus, it is difficult to evaluate
the treatment of TCM on AIDS simply through CD4+
T cell counts and plasma HIV viral loads.
In general, TCM practitioners mainly focus on the clin-
ical complaints of the patient and all those abnormal
symptoms and signs according to the theory of treat-
ment based on pattern and disease identification. Thus
they evaluate the treatment effects through the im-
provements of troublesome symptoms and signs,
health related quality of life, mental and spiritual, the
side-effects of cART, CD4+T cell counts and/or levels
of HIV loads; when they treat or change their strategy
for patients for the various objectives. Furthermore,
some researchers had adopted delayed time of asymp-
tomatic HIV infection to AIDS stage as evaluation end-
points in their studies.39
CONCLUSION
The roles of TCM on AIDS had been recognized and
accepted by more and more people. The asymptomatic
HIV infection stage is a relatively long period. From
the viewpoints of TCM, not only the imbalance of Yin
and Yang but also the disharmony of internal body
function and external natural environment had oc-
curred during the asymptomatic HIV infection stage.
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The imbalance and the disharmony can be restored by
TCM methods based on the patterns identified from
the symptoms for treatment. We do believe that asymp-
tomatic HIV infection stage is a good timing of using
TCM to manage the condition.
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